文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

COVID-19重症监护后的长期生存:一项纳入8000余例患者的全国性队列研究

Long-term survival after intensive care for COVID-19: a nationwide cohort study of more than 8000 patients.
PubMed 文献 · Ann Intensive Care · 2023-08-29
一句话结论瑞典全国队列显示,COVID-19 ICU患者360天死亡率为29.8%,男性较女性360天死亡风险升高(OR 1.33,95%CI 1.17-1.52)。

该全国性队列纳入截至2022年8月12日入住瑞典ICU的所有成人COVID-19患者,共8392例,中位年龄63岁(IQR 52-72),70.1%为男性。在7390例具有完整360天死亡数据的患者中,30天死亡1775例(24.4%)、90天死亡2125例(28.8%)、360天死亡2206例(29.8%)。女性360天死亡率为27.1%,男性为31.0%;多变量logistic回归显示男性较女性360天死亡风险升高(OR 1.33,95%CI 1.17-1.52)。年龄、心脏病、COPD/哮喘、糖尿病、免疫缺陷、慢性肾病、神经肌肉疾病和恶性肿瘤亦与较差的360天死亡率相关。作者认为,该研究证实了危重男性COVID-19患者病情更重,但90天后死亡率显著降低,提示急性期后存活概率高。

要点

  • 7390例完整随访患者中,ICU入科后360天死亡2206例(29.8%),其中30天内死亡1775例(24.4%)、90天内死亡2125例(28.8%)。
  • 女性360天死亡率为27.1%,男性为31.0%;多变量分析显示男性较女性360天死亡风险升高(OR 1.33,95%CI 1.17-1.52)。
  • 与360天死亡率升高相关的因素包括年龄、心脏病、COPD/哮喘、糖尿病、免疫缺陷、慢性肾病、神经肌肉疾病和恶性肿瘤。
  • 作者指出,90天后死亡率显著降低,提示急性期后存活概率高。

适用人群与场景

  • 截至2022年8月12日入住瑞典ICU的所有成人COVID-19患者,共8392例;中位年龄63岁(IQR 52-72),70.1%为男性。

研究设计与关键结果

  • 研究类型:全国性队列研究;纳入8392例成人COVID-19 ICU患者;主要终点为ICU入科后360天死亡率。
  • 在7390例具有完整360天死亡数据的患者中,30天内死亡1775例(24.4%),90天内死亡2125例(28.8%),360天内死亡2206例(29.8%)。
  • 女性360天死亡率为27.1%,男性为31.0%。
  • 多变量logistic回归显示,男性较女性360天死亡风险升高(OR 1.33,95%CI 1.17-1.52)。
  • 其他与较差360天死亡率相关的变量包括年龄、心脏病、COPD/哮喘、糖尿病、免疫缺陷、慢性肾病、神经肌肉疾病和恶性肿瘤。

证据类型、等级与局限

  • 证据类型:全国性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,该研究证实了危重男性COVID-19患者病情更重,即使在长期视角下也是如此;但90天后死亡率显著降低,提示急性期后存活概率高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Was it worth it-what is the outcome after the extended ICU (intensive care unit) length of stay for COVID-19 patients? Surprisingly, data on long-term mortality in large cohorts are lacking. We investigate long-term mortality including differences between men and women, as previous studies show that men generally suffer a more severe course of COVID-19 in terms of severity of illness and short-term mortality.

METHODS: Nationwide cohort including all adult COVID-19 patients admitted to Swedish ICUs until August 12, 2022. Primary outcome was 360-day mortality after ICU admission. Logistic regression was used to estimate associations between demographics, comorbidities, clinical characteristics and mortality.

RESULTS: In total, 8392 patients were included. Median (IQR) age was 63 (52-72) years and the majority (70.1%) were men. Among the 7390 patients with complete 360-day mortality data, 1775 (24.4%) patients died within 30 days, 2125 (28.8%) within 90 days and 2206 (29.8%) within 360 days from ICU admission. 360-day mortality was 27.1% in women and 31.0% in men. Multivariable logistic regression analysis showed increased risk of 360-day mortality in men compared to women (OR: 1.33, 95% CI: 1.17-1.52). Other variables associated with poor 360-day mortality were age, cardiac disease, COPD/asthma, diabetes, immune deficiency, chronic kidney disease, neuromuscular disease, and malignancy.

CONCLUSION: This study confirms the increased severity of disease in critically ill men with COVID-19, even in a long-term perspective. However, mortality beyond 90 days was strikingly low, indicating high probability of survival after the acute phase of illness.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Hägglöf E, Bell M, Zettersten E, et al. Long-term survival after intensive care for COVID-19: a nationwide cohort study of more than 8000 patients. Ann Intensive Care. 2023. PMID: 37642833. doi:10.1186/s13613-023-01156-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。